Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer

被引:0
|
作者
Chang Moo Kang
Yong Eun Chung
Jeong Youp Park
Jin Sil Sung
Ho Kyoung Hwang
Hye Jin Choi
Hyunki Kim
Si Young Song
Woo Jung Lee
机构
[1] Yonsei University College of Medicine,Division of Hepatobiliary and Pancreas, Department of Surgery
[2] Yonsei University College of Medicine,Division of Gastroenterology
[3] Yonsei University College of Medicine,Department of Internal Medicine
[4] Yonsei University College of Medicine,Department of Radiologic Oncology
[5] Yonsei University College of Medicine,Department of Radiology
[6] Yonsei University College of Medicine,Division of Medical Oncology
[7] Yonsei University College of Medicine,Department of Pathology
[8] Yonsei University Health System,Pancreaticobiliary Cancer Clinic, Institute of Gastroenterology
[9] Young Yonsei Panceatic Tumor Study Group,undefined
来源
关键词
Neoadjuvant; Chemoradiation; Pancreatic cancer; Borderline resectable;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:509 / 517
页数:8
相关论文
共 50 条
  • [21] Neoadjuvant Radiation Case Volume Is Associated with Improved Margin-Negative Resection Rate in Patients with Pancreatic Cancer
    Thalji, Sam
    Erickson, Beth A.
    Aldakkak, Mohammed
    Christians, Kathleen K.
    Clarke, Callisia
    Doucette, Saryn
    Evans, Douglas B.
    Tsai, Susan
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S152 - S152
  • [22] Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
    Stokes, Jayme B.
    Nolan, Norris J.
    Stelow, Edward B.
    Walters, Dustin M.
    Weiss, Geoffrey R.
    de Lange, Eduard E.
    Rich, Tyvin A.
    Adams, Reid B.
    Bauer, Todd W.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 619 - 627
  • [23] Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer
    Sopka, D. M.
    Chun, Y. S.
    Cohen, S. J.
    Zhu, F.
    Milestone, B. N.
    Cooper, H. S.
    Freedman, G. M.
    Burtness, B. A.
    Hoffman, J. P.
    Meyer, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S335 - S335
  • [24] Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
    Jayme B. Stokes
    Norris J. Nolan
    Edward B. Stelow
    Dustin M. Walters
    Geoffrey R. Weiss
    Eduard E. de Lange
    Tyvin A. Rich
    Reid B. Adams
    Todd W. Bauer
    Annals of Surgical Oncology, 2011, 18 : 619 - 627
  • [25] Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer
    Groot, Vincent P.
    Blair, Alex B.
    Gemenetzis, Georgios
    Ding, Ding
    Burkhart, Richard A.
    Yu, Jun
    Rinkes, Inne H. M. Borel
    Molenaar, I. Quintus
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    EJSO, 2019, 45 (09): : 1674 - 1683
  • [26] Neoadjuvant Therapy Followed by Surgical Resection for Borderline Resectable Pancreatic Cancer With Artery Involvement
    Yamaue, Hiroki
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    GASTROENTEROLOGY, 2015, 148 (04) : S1164 - S1164
  • [27] Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer
    Barrord, Michelle
    Ahmad, Syed
    Patel, Sameer
    Olowokure, Olugbenga
    Sussman, Jeffrey
    Smith, Milton
    Poreddy, Sampath
    Esslinger, Hope
    Latif, Tahir
    Choe, Kyuran
    Kharofa, Jordan
    PANCREAS, 2020, 49 (07) : 941 - 946
  • [28] Patterns of Failure Following Neoadjuvant SBRT or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer
    Barrord, M.
    Mierzwa, M. L.
    Ahmad, S.
    Olowokure, O.
    Sussman, J.
    Esslinger, H. R.
    Latif, T.
    Gupta, A.
    Smith, M.
    Poreddy, S.
    Kharofa, J. R., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E69 - E69
  • [29] Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer
    Suto, Hironobu
    Okano, Keiichi
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Tsuji, Akihito
    Masaki, Tsutomu
    Suzuki, Yasuyuki
    PANCREAS, 2022, 51 (03) : 269 - 277
  • [30] DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
    Hasegawa, Shinichiro
    Takahashi, Hidenori
    Akita, Hirofumi
    Mukai, Yosuke
    Mikamori, Manabu
    Asukai, Kei
    Yamada, Daisaku
    Wada, Hiroshi
    Fujii, Yoshiaki
    Sugase, Takahito
    Yamamoto, Masaaki
    Takeoka, Tomohira
    Shinno, Naoki
    Hara, Hisashi
    Kanemura, Takashi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Matsuda, Chu
    Yasui, Masayoshi
    Omori, Takeshi
    Miyata, Hiroshi
    Ohue, Masayuki
    Ishikawa, Osamu
    Sakon, Masato
    BMC CANCER, 2023, 23 (01)